So if you take out 2 & 3 (Avasitin & Humira). Avastin because dropped. Humira because its now all MNTA.
You have five potential candidates for the Mylan partnership - Orencia is not listed there so there is one extra. Any thoughts on which other one might have been dropped from Mylan partnership?